top of page
Search


Antisense Therapeutics - a purpose driven biotech with global potential
It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...
Jun 9, 20224 min read
361 views
0 comments


Recce Pharmaceuticals Limited – A revolution in development of treating superbugs
Recce Pharmaceuticals (ASX: RCE: FSE: R9Q) is a global leader in the new generation of anti-infective therapies. The company is listed on...
May 2, 20214 min read
207 views
0 comments


Antisense shares have increased by 60% after Sarepta results
Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...
Jan 8, 20212 min read
1,000 views
0 comments


mRNA and Antisense biotech - attracting the large fund managers and defining 2020
As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...
Dec 30, 20205 min read
3,803 views
0 comments


Ionis Pharmaceuticals - A force for life
RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...
Dec 9, 20203 min read
510 views
0 comments


Antisense Therapeutics Limited dual-lists in Europe
An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...
Nov 26, 20202 min read
121 views
0 comments
bottom of page